DeepScan Diagnostics
PrivateLast Round
Seed
Apr 21, 2026
Total Funding Raised
$6.01M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DeepScan Diagnostics operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a Seed round in April 2026.
DeepScan Diagnostics is a veterinary biotechnology company that provides diagnostic solutions for veterinarians, enabling early detection of canine cancer and other diseases through advanced CFD® biomarker testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepScan Diagnostics Comparables
Compare DeepScan Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CanCan Diagnostics | 84% | |
| testblu diagnostics | 83% | |
| Canos | 83% |
For institutional investors. Book with your work email.
DeepScan Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 21, 2026 | ||||
| Grant | Feb 3, 2025 | ||||
| Pre Seed | Nov 25, 2024 | ||||
| Grant | Feb 7, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DeepScan Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Pre Seed, Grant |
| Calm/Storm Ventures | Pre Seed, Seed |
| Runar Bäckström Foundation | Grant |
| Harjavalta Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 40% MoM, reaching 7.1K.
- Apr 21, 2026
$4M raised, led by Calm/Storm Ventures
For institutional investors. Book with your work email.
DeepScan Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DeepScan Diagnostics's valuation, stock price, and market status.
Is DeepScan Diagnostics a public or private company?
DeepScan Diagnostics is a private company.
What is the current stock price of DeepScan Diagnostics?
DeepScan Diagnostics is a private company, so its shares have no public market price. Caplight tracks DeepScan Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeepScan Diagnostics worth (valuation)?
Valuation information for DeepScan Diagnostics is not publicly available.
Can I buy DeepScan Diagnostics stock?
DeepScan Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeepScan Diagnostics's last funding round?
DeepScan Diagnostics's most recent funding round was Seed on April 21, 2026.
Who are the main investors in DeepScan Diagnostics?
Key investors in DeepScan Diagnostics include Calm/Storm Ventures.
Will DeepScan Diagnostics IPO soon?
No public IPO plans have been announced for DeepScan Diagnostics.
How can I track DeepScan Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in DeepScan Diagnostics's shares on secondary markets.